News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,509 Results
Type
Article (40850)
Company Profile (289)
Press Release (668370)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (206946)
Career Advice (2046)
Deals (35744)
Drug Delivery (98)
Drug Development (81930)
Employer Resources (174)
FDA (16235)
Job Trends (15042)
News (349352)
Policy (32835)
Tag
Academia (2584)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (50343)
ALS (92)
Alzheimer's disease (1392)
Antibody-drug conjugate (ADC) (127)
Approvals (16238)
Artificial intelligence (262)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11708)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (213)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (280)
Cancer (2291)
Cardiovascular disease (175)
Career advice (1711)
Career pathing (30)
CAR-T (155)
Cell therapy (437)
Cervical cancer (19)
Clinical research (66679)
Collaboration (853)
Company closure (1)
Compensation (548)
Complete response letters (19)
COVID-19 (2617)
CRISPR (42)
C-suite (248)
Cystic fibrosis (100)
Data (2235)
Decentralized trials (2)
Denatured (18)
Depression (45)
Diabetes (272)
Diagnostics (6408)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (87185)
Editorial (39)
Employer branding (21)
Employer resources (148)
Events (115344)
Executive appointments (741)
FDA (17521)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (765)
Gene editing (107)
Generative AI (21)
Gene therapy (313)
GLP-1 (718)
Government (4441)
Grass and pollen (4)
Guidances (75)
Healthcare (18914)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (117)
Indications (30)
Infectious disease (2760)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (99)
Interviews (315)
IPO (16627)
IRA (40)
Job creations (3746)
Job search strategy (1455)
Kidney cancer (10)
Labor market (38)
Layoffs (473)
Leadership (17)
Legal (7987)
Liver cancer (76)
Lung cancer (321)
Lymphoma (155)
Machine learning (7)
Management (58)
Manufacturing (315)
MASH (68)
Medical device (13404)
Medtech (13409)
Mergers & acquisitions (19662)
Metabolic disorders (696)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (27)
Neuroscience (1935)
NextGen: Class of 2025 (6584)
Non-profit (4509)
Now hiring (39)
Obesity (370)
Opinion (216)
Ovarian cancer (76)
Pain (87)
Pancreatic cancer (86)
Parkinson's disease (149)
Partnered (21)
Patents (237)
Patient recruitment (113)
Peanut (47)
People (58367)
Pharmaceutical (68)
Pharmacy benefit managers (18)
Phase I (20857)
Phase II (29410)
Phase III (21754)
Pipeline (1217)
Policy (142)
Postmarket research (2572)
Preclinical (8884)
Press Release (71)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (248)
Rare diseases (383)
Real estate (6072)
Recruiting (67)
Regulatory (22493)
Reports (46)
Research institute (2353)
Resumes & cover letters (354)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (131)
Series B (88)
Service/supplier (11)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3685)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (41)
The Weekly (30)
Vaccines (694)
Venture capitalists (42)
Weight loss (240)
Women's health (35)
Worklife (16)
Date
Today (129)
Last 7 days (935)
Last 30 days (2623)
Last 365 days (33144)
2025 (11011)
2024 (35647)
2023 (40439)
2022 (51646)
2021 (56116)
2020 (54486)
2019 (46925)
2018 (35353)
2017 (32536)
2016 (32061)
2015 (38048)
2014 (31823)
2013 (26862)
2012 (29179)
2011 (29853)
2010 (27943)
Location
Africa (748)
Alabama (53)
Alaska (7)
Arizona (235)
Arkansas (13)
Asia (38829)
Australia (6472)
California (6235)
Canada (2034)
China (532)
Colorado (268)
Connecticut (280)
Delaware (150)
Europe (83958)
Florida (917)
Georgia (208)
Idaho (57)
Illinois (566)
India (25)
Indiana (314)
Iowa (11)
Japan (166)
Kansas (108)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (904)
Massachusetts (4662)
Michigan (221)
Minnesota (393)
Mississippi (2)
Missouri (81)
Montana (30)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1760)
New Mexico (29)
New York (1771)
North Carolina (997)
North Dakota (8)
Northern California (2723)
Ohio (205)
Oklahoma (14)
Oregon (34)
Pennsylvania (1393)
Puerto Rico (12)
Rhode Island (33)
South America (1137)
South Carolina (23)
South Dakota (1)
Southern California (2341)
Tennessee (103)
Texas (922)
United States (23524)
Utah (185)
Virginia (149)
Washington D.C. (62)
Washington State (562)
West Virginia (3)
Wisconsin (55)
709,509 Results for "syngenta biotechnology inc sbi".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division
April 23, 2025
·
3 min read
Press Releases
Groundbreaking New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at SBI
April 24, 2025
·
4 min read
Press Releases
Transpara® Showcases Innovative FDA Cleared Breast AI Capabilities including Breast Density Assessment and Temporal Comparison to Elevate Radiologist Performance at SBI
April 16, 2025
·
3 min read
Press Releases
GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
April 25, 2025
·
8 min read
Press Releases
Spiderwort Biotechnologies Inc. Announces Status of Biocompatibility Testing for CelluJuve®
April 30, 2025
·
3 min read
Press Releases
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
April 23, 2025
·
6 min read
Business
Syngenta Group Reports H1 2023 Results
Syngenta Group announced financial results for the first half and the second quarter of 2023.
August 31, 2023
·
10 min read
Drug Development
Skye Bioscience Treats First Patient in Glaucoma Phase 2 Study of SBI-100 Ophthalmic Emulsion
Skye Bioscience, Inc. has treated the first patient in its Phase 2 clinical trial evaluating SBI-100 Ophthalmic Emulsion’s (“OE”) ability to lower intraocular pressure (“IOP”), safety and relevant biomarkers, in patients with primary open-angle glaucoma (“POAG”) or ocular hypertension (“OHT”).
November 28, 2023
·
6 min read
News
Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals
July 16, 2024
·
7 min read
Press Releases
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
March 7, 2025
·
8 min read
1 of 70,951
Next
